This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
CareTrust REIT (CTRE) Matches Q4 FFO Estimates
by Zacks Equity Research
CareTrust REIT (CTRE) delivered FFO and revenue surprises of 0% and 3.42%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?
Unlocking Q4 Potential of CareTrust REIT (CTRE): Exploring Wall Street Estimates for Key Metrics
by Zacks Equity Research
Looking beyond Wall Street's top -and-bottom-line estimate forecasts for CareTrust REIT (CTRE), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended December 2024.
Welltower Establishes Private Funds Management Business
by Zacks Equity Research
To manage third-party capital and invest across capital structures in the wellness and healthcare real estate, WELL launches a private funds management business.
Welltower's Affiliate to Acquire NorthStar Healthcare for $900M
by Zacks Equity Research
WELL is set to acquire NorthStar Healthcare and its portfolio of 40 senior living communities.
Ensign Group Bolsters Healthcare Portfolio With Nine New Facilities
by Zacks Equity Research
ENSG acquires operations of nine skilled nursing facilities, marking its debut in Alabama and strengthening its Tennessee footprint, to enhance care and grow its Skilled Services segment.
After Plunging -8.29% in 4 Weeks, Here's Why the Trend Might Reverse for CareTrust REIT (CTRE)
by Zacks Equity Research
CareTrust REIT (CTRE) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
2 Healthcare REIT Stocks to Buy Before Moving Into 2025
by Rohit Vasant Fatarpekar
Healthcare REIT stocks are expected to benefit from an aging population, rising healthcare expenditure and technological advancements as they head into 2025.
OUTFRONT Media Stock Rises 33% in 6 Months: Will the Trend Last?
by Zacks Equity Research
Geographically diversified advertising sites, digital billboard conversions and strategic buyouts are likely to support OUT's performance in the quarters ahead.
Prologis Sells Chicago-Based Data Center Development to HMC Capital
by Zacks Equity Research
PLD announces the sale of data center development to HMC Capital in Chicago.
Down -6.3% in 4 Weeks, Here's Why CareTrust REIT (CTRE) Looks Ripe for a Turnaround
by Zacks Equity Research
CareTrust REIT (CTRE) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
SLG Raises 2024 FFO Guidance, Announces Lease Renewal & Transactions
by Zacks Equity Research
SL Green raises 2024 FFO per share guidance, secures lease renewal and announces a series of transactions at 100 Park Avenue building.
SL Green Rewards Investors With Dividend Hike: Is it Sustainable?
by Zacks Equity Research
SLG's latest dividend hike reflects its ability to generate decent cash flows from its high-quality portfolio.
Ventas' Tenant Brookdale Opts Out to Exercise Lease Extension
by Zacks Equity Research
Brookdale Senior Living, a tenant of VTR, chooses not to exercise the extension term of Master Lease.
CareTrust REIT (CTRE) Reports Q3 Earnings: What Key Metrics Have to Say
by Zacks Equity Research
The headline numbers for CareTrust REIT (CTRE) give insight into how the company performed in the quarter ended September 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
CareTrust REIT (CTRE) Q3 FFO Match Estimates
by Zacks Equity Research
CareTrust REIT (CTRE) delivered FFO and revenue surprises of 0% and 4.40%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?
All You Need to Know About CareTrust REIT (CTRE) Rating Upgrade to Buy
by Zacks Equity Research
CareTrust REIT (CTRE) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
CareTrust Buys 4 Nursing Facilities in Mid-Atlantic for $74.7M
by Zacks Equity Research
CTRE acquires four skilled nursing facilities in Mid-Atlantic to grow its healthcare portfolio.
Medical Properties Resumes Control of its Real Estate From Steward
by Zacks Equity Research
MPW settles with the Steward Health Care System by reinstating control over its real estate to safeguard the essential operations of these facilities.
Is it a Wise Decision to Hold Healthpeak Properties Stock Now?
by Zacks Equity Research
DOC is well-poised to gain from high demand for lab assets and rising senior citizens' healthcare spending despite competitive and high interest rate environment.
CareTrust REIT (CTRE) Is Up 4.96% in One Week: What You Should Know
by Zacks Equity Research
Does CareTrust REIT (CTRE) have what it takes to be a top stock pick for momentum investors? Let's find out.
Best Momentum Stock to Buy for August 28th
by Zacks Equity Research
QFIN, CTRE and BPMUF made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on August 28, 2024.
3 Highly Ranked REITs to Buy with Rate Cuts Ahead
by Shaun Pruitt
With the possibility of multiple rate cuts back on the table this year, Real Estate Investment Trusts (REITs) may stand to benefit the most as these equities rely on debt to finance their operations and acquire properties.
Medical Properties (MPW) Disposes of 11 Facilities to UCHealth
by Zacks Equity Research
In line with its capital recycling strategy, Medical Properties (MPW) sells 11 facilities in Colorado to University of Colorado Health for $86 million.
Are You Looking for a Top Momentum Pick? Why CareTrust REIT (CTRE) is a Great Choice
by Zacks Equity Research
Does CareTrust REIT (CTRE) have what it takes to be a top stock pick for momentum investors? Let's find out.
CareTrust REIT (CTRE) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
by Zacks Equity Research
The headline numbers for CareTrust REIT (CTRE) give insight into how the company performed in the quarter ended June 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.